127 related articles for article (PubMed ID: 18936108)
1. Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.
Fang JL; McGarrity LJ; Beland FA
Mutagenesis; 2009 Mar; 24(2):133-41. PubMed ID: 18936108
[TBL] [Abstract][Full Text] [Related]
2. Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.
Fang JL; Beland FA
Toxicol Sci; 2009 Sep; 111(1):120-30. PubMed ID: 19541796
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in B6C3F(1)/Tk+/- mice treated neonatally with zidovudine and lamivudine.
Von Tungeln LS; Hamilton LP; Dobrovolsky VN; Bishop ME; Shaddock JG; Heflich RH; Beland FA
Carcinogenesis; 2002 Sep; 23(9):1427-32. PubMed ID: 12189183
[TBL] [Abstract][Full Text] [Related]
5. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
6. A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine.
Kemp SD; Shi C; Bloor S; Harrigan PR; Mellors JW; Larder BA
J Virol; 1998 Jun; 72(6):5093-8. PubMed ID: 9573280
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
9. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
Smith RA; Remington KM; Preston BD; Schinazi RF; North TW
J Virol; 1998 Mar; 72(3):2335-40. PubMed ID: 9499094
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice.
Venerosi A; Valanzano A; Alleva E; Calamandrei G
Teratology; 2001 Jan; 63(1):26-37. PubMed ID: 11169552
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Jan; (569):1-212. PubMed ID: 23385634
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.
Desai VG; Lee T; Delongchamp RR; Leakey JE; Lewis SM; Lee F; Moland CL; Branham WS; Fuscoe JC
Mitochondrion; 2008 Mar; 8(2):181-95. PubMed ID: 18313992
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatographic-mass spectrometric determination of the metabolism and disposition of the anti-retroviral nucleoside analogs zidovudine and lamivudine in C57BL/6N and B6C3F1 mice.
Williams LD; Von Tungeln LS; Beland FA; Doerge DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):55-62. PubMed ID: 14630359
[TBL] [Abstract][Full Text] [Related]
15. Effects of prenatal AZT+3TC treatment on open field behavior and responsiveness to scopolamine in adult mice.
Calamandrei G; Venerosi A; Valanzano A; Alleva E
Pharmacol Biochem Behav; 2000 Nov; 67(3):511-7. PubMed ID: 11164081
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.
von Wyl V; Ehteshami M; Symons J; Bürgisser P; Nijhuis M; Demeter LM; Yerly S; Böni J; Klimkait T; Schuurman R; Ledergerber B; Götte M; Günthard HF;
J Infect Dis; 2010 Apr; 201(7):1054-62. PubMed ID: 20170373
[TBL] [Abstract][Full Text] [Related]
17. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
[TBL] [Abstract][Full Text] [Related]
18. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of 3'-azido-3'-deoxythymidine on the cell cycle of HL60 cells.
Roskrow M; Wickramasinghe SN
Clin Lab Haematol; 1990; 12(2):177-84. PubMed ID: 2208948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
